Novel oncolytic viruses: riding high on the next wave?
- PMID: 20219409
- DOI: 10.1016/j.cytogfr.2010.02.012
Novel oncolytic viruses: riding high on the next wave?
Abstract
The use of viruses as targeted cancer therapy has shown significant promise, and the list of oncolytic viruses continue to grow. The interest in unexplored viruses as oncolytic agents is a natural corollary to the successes and challenges of those already being examined in the clinical setting. Are these 'new' viruses any more effective than their predecessors? What are the benefits of refining current clinical candidates compared to searching for new ones? This review briefly describes some of these novel oncolytic viruses. It also examines the issues that arise in comparing them to each other. We believe that the viral mechanism of action is a key factor to success and suggest guidelines by which all oncolytic virus candidates could be evaluated.
Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Gene therapy progress and prospects cancer: oncolytic viruses.Gene Ther. 2008 Jun;15(12):877-84. doi: 10.1038/gt.2008.72. Epub 2008 Apr 17. Gene Ther. 2008. PMID: 18418413 Review.
-
ReVOLT: radiation-enhanced viral oncolytic therapy.Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):637-46. doi: 10.1016/j.ijrobp.2006.06.034. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011442 Review.
-
A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.Gene Ther. 2007 Apr;14(8):638-47. doi: 10.1038/sj.gt.3302914. Epub 2007 Feb 1. Gene Ther. 2007. PMID: 17268533
-
Naturally oncolytic viruses.Curr Opin Mol Ther. 2006 Aug;8(4):314-21. Curr Opin Mol Ther. 2006. PMID: 16955694 Review.
-
Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.Arch Immunol Ther Exp (Warsz). 2008 Dec;56 Suppl 1:3s-59s. doi: 10.1007/s00005-008-0047-9. Epub 2008 Dec 23. Arch Immunol Ther Exp (Warsz). 2008. PMID: 19104757 Review.
Cited by
-
Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model.Hum Gene Ther. 2012 Aug;23(8):871-82. doi: 10.1089/hum.2012.040. Epub 2012 Jun 25. Hum Gene Ther. 2012. PMID: 22551458 Free PMC article.
-
The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies.Curr Gene Ther. 2012 Feb 1;12(1):33-47. doi: 10.2174/156652312799789235. Curr Gene Ther. 2012. PMID: 22263922 Free PMC article. Review.
-
Inhibitors of C5 complement enhance vaccinia virus oncolysis.Cancer Gene Ther. 2013 Jun;20(6):342-50. doi: 10.1038/cgt.2013.26. Epub 2013 May 10. Cancer Gene Ther. 2013. PMID: 23661042 Free PMC article.
-
Trial watch: Oncolytic viruses for cancer therapy.Oncoimmunology. 2013 Jun 1;2(6):e24612. doi: 10.4161/onci.24612. Epub 2013 Apr 16. Oncoimmunology. 2013. PMID: 23894720 Free PMC article.
-
A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4.Oncotarget. 2015 Aug 21;6(24):20345-55. doi: 10.18632/oncotarget.3884. Oncotarget. 2015. PMID: 25972362 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources